Stephenson Harwood LLP has advised Shield Therapeutics plc on its £12 million fundraise by way of a co-ordinated exercise of existing warrants, subscription of new ordinary…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
